Type I IFN, TLR7, MHC Class I, B Cell and OX40 Pathways Suppressed By Anifrolumab (anti-type I IFN receptor) in Moderate to Severe SLE Patients

被引：0
|
作者：
Streicher, Katie [1 ]
Wang, Jixin [1 ]
Brohawn, Philip Z. [2 ]
Higgs, Brandon W. [2 ]
Tummala, Raj [3 ]
Ranade, Koustubh [1 ]
机构：
[1] MedImmune, Translat Med, Gaithersburg, MD USA
[2] MedImmune LLC, Gaithersburg, MD USA
[3] MedImmune, Gaithersburg, MD USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2018年 / 70卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2684
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Type I IFN Drives a Distinctive Dendritic Cell Maturation Phenotype That Allows Continued Class II MHC Synthesis and Antigen Processing
    Simmons, Daimon P.
    Wearsch, Pamela A.
    Canaday, David H.
    Meyerson, Howard J.
    Liu, Yi C.
    Wang, Ying
    Boom, W. Henry
    Harding, Clifford V.
    JOURNAL OF IMMUNOLOGY, 2012, 188 (07): : 3116 - 3126
  • [32] Distinctive TLR7 Signaling, Type I IFN Production, and Attenuated Innate and Adaptive Immune Responses to Yellow Fever Virus in a Primate Reservoir Host
    Mandl, Judith N.
    Akondy, Rama
    Lawson, Benton
    Kozyr, Natalia
    Staprans, Silvija I.
    Ahmed, Rafi
    Feinberg, Mark B.
    JOURNAL OF IMMUNOLOGY, 2011, 186 (11): : 6406 - 6416
  • [33] An alternative signal 3: CD8+ T cell memory independent of IL-12 and type I IFN is dependent on CD27/OX40 signaling
    Sanchez, Phillip J.
    Kedl, Ross M.
    VACCINE, 2012, 30 (06) : 1154 - 1161
  • [34] IRF3 and IRF7 are key Elements of the Type I IFN Response in Patients with Hepatitis B
    Schwarz, David
    Churin, Yuri
    Mollenkopf, Hans-Joachim
    Roderfeld, Martin
    Roeb, Elke
    INTERNIST, 2018, 59 : S38 - S38
  • [35] Type I IFN Contributes to the Phenotype of Unc93b1D34A/D34A Mice by Regulating TLR7 Expression in B Cells and Dendritic Cells
    Fukui, Ryutaro
    Kanno, Atsuo
    Miyake, Kensuke
    JOURNAL OF IMMUNOLOGY, 2016, 196 (01): : 416 - 427
  • [36] TLR2 Promotes Th2/Th17 Responses via TLR4 and TLR7/8 by Abrogating the Type I IFN Amplification Loop
    Wenink, Mark H.
    Santegoets, Kim C. M.
    Broen, Jacobus C. A.
    van Bon, Lenny
    Abdollahi-Roodsaz, Shahla
    Popa, Calin
    Huijbens, Richard
    Remijn, Thijs
    Lubberts, Erik
    van Riel, Piet L. C. M.
    van den Berg, Wim B.
    Radstake, Timothy R. D. J.
    JOURNAL OF IMMUNOLOGY, 2009, 183 (11): : 6960 - 6970
  • [37] Target Modulation of a Type I Interferon (IFN) Gene Signature with Sifalimumab or Anifrolumab in Systemic Lupus Erythematosus (SLE) Patients in Two Open Label Phase 2 Japanese Trials
    Morehouse, Chris
    Chang, Linda
    Wang, Liangwei
    Brohawn, Philip
    Ueda, Shinya
    Illei, Gabor
    Greth, Warren
    Yoo, Stephen
    Roskos, Lorin
    Yao, Yihong
    Robbie, Gabriel
    Higgs, Brandon W.
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S313 - S314
  • [38] Type I IFN Blockade Restores Normal Transitional B Cell Development Post-Anti-CD20 Depletion
    Hamilton, Jennie
    Wu, Qi
    Yang, PingAr
    Luo, Bao
    Liu, Shanrun
    Hong, Huixian
    Li, Jun
    Hsu, Hui-Chen
    Mountz, John D.
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [39] Autocrine/paracrine IL-15 that is required for type I IFN-mediated dendritic cell expression of MHC class I-related chain A and B is impaired in hepatitis C virus infection
    Jinushi, M
    Takehara, T
    Tatsumi, T
    Kanto, T
    Groh, V
    Spies, T
    Suzuki, T
    Miyagi, T
    Hayashi, N
    JOURNAL OF IMMUNOLOGY, 2003, 171 (10): : 5423 - 5429
  • [40] Sphingosine Analogue AAL-R Increases TLR7-Mediated Dendritic Cell Responses via p38 and Type I IFN Signaling Pathways
    Seo, Young-Jin
    Pritzl, Curtis J.
    Vijayan, Madhuvanthi
    Blake, Celeste R.
    McClain, Mariah E.
    Hahm, Bumsuk
    JOURNAL OF IMMUNOLOGY, 2012, 188 (10): : 4759 - 4768
12345